3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
3
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Carcinoma, Non-Small-Cell Lung
25
Ovarian Neoplasms
23
Breast Neoplasms
22
Lung Neoplasms
19
Lymphoma
18
Carcinoma, Ovarian Epithelial
18
Neoplasm Metastasis
14
Colorectal Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
12
Sarcoma
12
Head and Neck Neoplasms
12
Urinary Bladder Neoplasms
10
Prostatic Neoplasms
10
Colonic Neoplasms
10
Central Nervous System Neoplasms
10
Astrocytoma
10
Rectal Neoplasms
9
Multiple Myeloma
9
Uterine Cervical Neoplasms
8
Oligodendroglioma
8
Mycosis Fungoides
8
Fallopian Tube Neoplasms
8
Adenocarcinoma of Lung
8
Stomach Neoplasms
7
Recurrence
7
Melanoma
7
Medulloblastoma
7
Brain Neoplasms
7
Sezary Syndrome
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Interventions
ixazomib
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
NETWORK
×
Genetic Diseases, Inborn
×
Clear all
NCT03683277
2025-02-19
IFM2014-01
Intergroupe Francophone du Myelome
Phase 2
Terminated
26 enrolled